跳至主要内容
临床试验/NCT01553838
NCT01553838已完成不适用

A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values

Heinrich-Heine University, Duesseldorf2 个研究点 分布在 1 个国家目标入组 185 人开始时间: 2012年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
185
试验地点
2
主要终点
Prostate cancer detection rate

研究概览

简要总结

The purpose of this study is to determine whether MRI guided prostate biopsy achieves higher prostate cancer detection rates compared with transrectal ultrasound guided prostate biopsy in patients with increased PSA values > 4.0 ng/ml.

研究设计

研究类型
Interventional
干预模型
Crossover
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • PSA > 4.0 ng/ml
  • written informed consent

排除标准

  • patients with prostate cancer
  • patients with prior prostate biopsy
  • patients with contraindications against MRI or biopsy

研究组 & 干预措施

Sequentially MRI guided and TRUS guided biopsy

Experimental

Targeted MRI guided biopsy according to findings in a multiparametric MRI followed by transrectal guided biopsy

干预措施: MRI guided prostate biopsy and TRUS guided biopsy (Device)

结局指标

主要结局

Prostate cancer detection rate

时间窗: 3 years

次要结局

  • Number of Participants with Adverse Events as a measure of Safety and Tolerability(3 years)

研究者

发起方
Heinrich-Heine University, Duesseldorf
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Prospective Study to Evaluate MRI Guided Biopsy... | 临床试验